Back to mobile site

Amgen (AMGN) Announces it Won Patent Case on Enbrel

August 9, 2019 4:06 PM EDT Send to a Friend
Amgen (NASDAQ: AMGN) today announced that the U.S. District Court for the District of New Jersey has ruled in Amgen's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login